Envista
DEXIS™ announces a new advancement in implant dentistry workflows with the DEXIS digital ecosystem: an interconnected, AI-powered platform for digital implants - combining cutting-edge CBCT, intraoral scanning, diagnostics, and treatment planning. The ecosystem is designed to empower clinicians to manage each step of an implant case, from diagnosis to delivery, with one integrated tool set.
QUAKERTOWN, PA / ACCESSWIRE / February 12, 2024 / For over 70 years, DEXIS has been committed to providing clinicians with smart tools to accurately diagnose patients, create treatment plans, and achieve desired outcomes. The DEXIS digital ecosystem is no exception and continues to uphold that same tradition of excellence. With this prosthetic-driven implant system, you'll gain access to an open imaging platform, complete with diagnostics and treatment planning software, driven by Assisted Intelligence and tailored specifically for implant workflows.
Recognizing the daily challenges of managing data, processes and expectations, the DEXIS digital ecosystem takes pride in its simplicity. This user-friendly platform allows clinicians to efficiently organize, analyze and plan cases while seamlessly collaborating with team members and partners.
"I can complete each step of a clinical case from within one software - educating the patient, making a diagnosis, creating a treatment plan and gaining acceptance," said Dr. Katya Archambault, Oral and Maxillofacial Radiologist in La Jolla, California. "My staff loves it because they don't have to pull up tons of different programs. It's all just very clear, clean and on the same page."
In late 2023, DEXIS launched the ORTHOPANTOMOGRAPH™ OP 3D™ LX, an advanced cone beam computed tomography technology that enhances 3D diagnostic capabilities with flexible FOV options and short scan times, boosting diagnostic confidence and supporting an evolving practice.
"At DEXIS, our product development team worked with over 200 dentists and their teams to put the customer at the center of our solutions," said Brian Gooch, Global Product Management and Marketing Vice President at DEXIS. "With implant workflows, the DEXIS solution promotes diagnostic confidence and delivers productivity to the office. We are always in motion, driven by a profound commitment to innovate and improve our solutions for clinics striving for a more efficient way of working."
After launching the OP 3D LX, DEXIS announced the release of an upgraded version of its intraoral scanning software - IS ScanFlow. Through guided workflows and the use of AI-powered tools, users can confidently navigate complex scanning situations and consistently acquire accurate data. A good example of this is the new full arch workflow, which assists users in obtaining scan data for full-mouth rehabilitations, providing step-by-step guidance throughout the process.
"We've used the new full arch workflow," said Dr. Robert Pauley, practice owner in Union City, Georgia. "It's very easy to take the common scan with the provisional in place, remove and scan the provisional and then obtain a final scan of the soft tissue with scanbodies."
DEXIS has also brought advancements to the core platform of its digital ecosystem, DTX Studio™ Clinic - an AI-driven diagnostic and treatment planning software. DTX Studio Clinic seamlessly integrates with the DEXIS intraoral scanning solution, serving as the central hub for clinicians to manage all patient data and files. With a clear and reliable source of information for each case, DTX Studio Clinic effortlessly assists with every step of the process, from dental imaging and diagnostics to treatment planning, manufacturing, and follow-up.
With an array of AI-driven tools to enhance the implant process, DTX Studio Clinic prioritizes high productivity and effective communication. Assisted Intelligence streamlines your diagnostics by preparing CBCT images, automatically annotating features like tooth positions and panoramic curves, and tracing the mandibular nerve canal - saving you time and effort. Additionally, the automated merging of CBCT and optical scans creates a realistic 3D digital rendering of a patient's dentition for accurate treatment planning.
Clinicians have the freedom to customize their workflow, while ensuring that patients, labs, and staff have the visibility they need for a seamless experience. This is accomplished through a variety of tools and features, including:
- AI-assisted case setup for chairside diagnostics and treatment planning
- Dynamic view of images, findings and treatment plans all on one screen
- Automatic merging of CBCT and intraoral scans
- AI-powered powered tooth number recognition
- AI-powered automated tooth setup
- AI-powered focus area identification
- Assisted mandibular nerve canal tracing
- Assisted airway identification
- Easy partner access to all digital files
- Cross-practice access to all information from any computer
- Virtual implant library
- Surgical guide creation to 3D print in-house or for outsourcing
- Dynamic surgery with X-Guide
The DEXIS digital ecosystem empowers clinicians to manage their entire implant process with one, integrated toolset, while preserving complete flexibility to adapt their workflows based on the individual needs of each case. With this uniquely connected platform, clinicians now have the freedom to personalize their workflows and the standardization to scale them.
Explore the DEXIS digital ecosystem here.
About DEXIS
DEXIS has been a global leading brand in digital radiography for 70+ years. Today, DEXIS has brought together the most trusted brands in 3D imaging, intraoral scanning solutions, and diagnostic software to provide you with a complete digital diagnostic solution under a brand name. Our innovative award-winning technology enhances the way you diagnose, accelerates your workflow, and delivers simpler treatment paths with better patient outcomes. For more information, please visit https://www.dexis.com.
Contact Information
Hayley Reed
Regional Marketing Director, DEXIS IOS
hayley.reed@envistaco.com
(714) 628-8533
SOURCE: DEXIS
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Germany Buys Eight MQ-9B SeaGuardian(R) RPA Through NSPA12.1.2026 20:00:00 CET | Press release
NSPA Supports NATO Countries in the Acquisition and Sustainment of GA-ASI's Advanced Multi-Domain RPA SAN DIEGO, CALIFORNIA / ACCESS Newswire / January 12, 2026 / Germany's Federal Office of Bundeswehr Equipment, Information Technology and In-Service Support and the NATO Support and Procurement Agency (NSPA) have announced the procurement of eight MQ-9B SeaGuardian® Remotely Piloted Aircraft (RPA) from General Atomics Aeronautical Systems, Inc. (GA-ASI). The program includes four Certifiable Ground Control Stations. First delivery is expected in 2028. Germany joins a growing list of NATO countries that have selected GA-ASI's advanced MQ-9B RPA for its multi-domain capabilities with exceptionally long range and endurance. The platform provides pole-to-pole satellite control and de-icing capabilities to enable missions in cold climates. SeaGuardian features two multi-mode surface-search radars that deliver wide-area maritime surveillance, with an option to add Anti-Submarine Warfare capa
Datavault AI Announces Target to Expand its AI Driven Data Monetization Network to Over 100 Cities Across the Contiguous United States, Starting in the Second Half of 2026 with Corresponding 2027 Revenue Target12.1.2026 14:05:00 CET | Press release
Datavault AI expects to have a fully operational network with over 100 nodes across 33 cities nationwide, generating revenue in the second half of 2026. Target revenue for this project is $400 to $500 million, thereby supporting the $200 million revenue guidance for 2026. With the full deployment of Datavault AI's nodes across 100+ cities throughout the United States, the 2027 revenue target is $2.0 to $3.0 billion for 2027. New York and Philadelphia edge network activation positions Datavault AI to potentially capture a significant share of the insurance and financial sectors, the healthcare industry, and enterprise opportunities. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in AI-driven data valuation, monetization, credentialing, and digital engagement technologies, today highlighted the strategic importance of its New York and Philadelphia edge network deployment with Available Infrastructure's SanQtum AI platform. This
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC12.1.2026 13:00:00 CET | Press release
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has entered into a commercial license agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based biopharma focused on developing antibodies targeting cancer-associated glycans and glycoproteins, for a glycan-targeting ADC. Under the terms of the agreement, OBI is eligible to receive an upfront payment as well as development and commercial milestones. Following product launch, OBI will also receive royalties based on a tiered percentage of annual net sales. While the detailed financial terms are not disclosed in accordance with the confidentiality provisions, the overall deal economics are broadly comparable to those of recent similar licensing transactions in the market. TegMine will obtain the exclusive global rights to develop and commercialize the ADC under the license agreemen
Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access12.1.2026 12:00:00 CET | Press release
SBX Product Line Will Feature First-Ever AI-Powered Blockchain-Based Age-Gating System for Vape Products IKE's patented biometric BLE Bluetooth chip and blockchain-based app will enable Charlie's to ensure that underage individuals will not be able to activate or utilize the Company's age-gated products. The IKE Licensing Agreement provides CHUC with a first mover advantage in youth access prevention (one of the FDA's top priorities) and a three-year exclusivity period for age-gated nicotine analogue products. Charlie's will test market the IKE age-gating system this spring with the Company's popular SBX nicotine analogue product line; simultaneously, Charlie's intends to incorporate the revolutionary technology into its PACHA branded Electronic Nicotine Delivery Systems (ENDS). COSTA MESA, CA / ACCESS Newswire / January 12, 2026 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Compan
Datavault AI Celebrates Successful Completion of Dream Bowl XIV, Pioneering Blockchain Innovation in Sports Entertainment12.1.2026 12:00:00 CET | Press release
On January 10, 2026, a few dozen of NFL Alumni Greats (click here for a list of participating athletes) live-autographed 100 Footballs (click here to view the autographed NFL Alumni Footballs) and 500 Jerseys (click here to view the autographed NFL Alumni Jerseys); Starting on February 1, 2026, these special, one-time, live-autographed memorabilia items are to be given away by lottery to eligible holders of Dream Bowl Meme Coin I tokens and, following their distribution date (currently set for February 21, 2026), Dream Bowl Meme Coin II tokens and will be tradable on the upcoming International NIL Exchange; $25,000 E-Sports Scholarships Raised by Sponsors were Given to Dream Bowl Madden and Team E-Sports Champions; and 70 Student Star Athletes Showcased their Talent to USFL, NFL and European League Scouts (click here to view the Special Dream Bowl XIV Participants' Jerseys). PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom